International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) against gp120-gp41 interface epitopes has expanded the targetable surface on the HIV-1 envelope glycoprotein (Env) trimer. By using biochemical, biophysical and computational methods, we map the previously unknown trimer epitopes of two related antibodies, 3BC315 and 3BC176. A cryo-EM reconstruction of a soluble Env trimer bound to 3BC315 Fab at 9.3 Å resolution reveals that the antibody binds between two gp41 protomers, and neutralizes the virus by accelerating trimer decay. In contrast, bnAb 35O22 binding to a partially overlapping quaternary epitope at the gp120-gp41 interface does not induce decay. A conserved gp41-proximal glycan at N88 was...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1 infected individuals inform vaccine desi...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
The recent identification of three broadly neutralizing antibodies (bnAbs) against gp120–gp41 interf...
The trimeric envelope glycoproteins (Env) on the surface of HIV-1 virions are the targets for neutra...
<div><p>The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating...
SummaryAll previously characterized broadly neutralizing antibodies to the HIV-1 envelope glycoprote...
The HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs)...
SummaryThe HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies ...
The HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs)...
The induction by vaccination of broadly neutralizing antibodies (bNAbs) capable of neutralizing vari...
The induction of broadly HIV-1 neutralizing antibodies (bNAbs) by vaccination is challenging, but un...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1 infected individuals inform vaccine desi...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
International audienceThe recent identification of three broadly neutralizing antibodies (bnAbs) aga...
The recent identification of three broadly neutralizing antibodies (bnAbs) against gp120–gp41 interf...
The trimeric envelope glycoproteins (Env) on the surface of HIV-1 virions are the targets for neutra...
<div><p>The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating...
SummaryAll previously characterized broadly neutralizing antibodies to the HIV-1 envelope glycoprote...
The HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs)...
SummaryThe HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies ...
The HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs)...
The induction by vaccination of broadly neutralizing antibodies (bNAbs) capable of neutralizing vari...
The induction of broadly HIV-1 neutralizing antibodies (bNAbs) by vaccination is challenging, but un...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1 infected individuals inform vaccine desi...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...